0 items USD 0.00Search
- Did you mean
- crown diseases
Your search for "crohn diseases" gave back 100410 results.
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
February 2024
Price: USD 2,900.00
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
December 2021
Price: USD 3,500.00
Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
An ostomy, or stoma refers to the surgical procedure in which diseased portion of gastrointestinal or urinary system is removed, accompanied by...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Rockville Research
November 2018
Price: USD 1,500.00
The global Remicade (infliximab) Drug market size was valued at US$ 2494.5 million in 2023. With growing demand in downstream market, the Remicade (...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
The global Inflammatory Bowel Disease market size was valued at US$ 12530 million in 2023. With growing demand in downstream market, the Inflammatory...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
December 2024
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 15980 million in 2024 and is forecast to a readjusted size of USD 8906 million by 2031 with a CAGR of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
February 2025
Price: USD 3,480.00
The global Inflammatory Bowel Disease (IBD) Treatment market size was valued at US$ 1579.4 million in 2023. With growing demand in downstream market...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2018 Summary Intercellular Adhesion...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
January 2018
Price: USD 3,500.00
The global Human Microbiome Therapeutics market size was valued at USD 993.6 million in 2023 and is forecast to a readjusted size of USD 1590.1...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
July 2024
Price: USD 3,480.00
Ìý
Filter By Report Date
Filter By Industry
Filter By Country
- Global (99963) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Â鶹Դ´s (1) Apply Emerging Â鶹Դ´s filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
